Related Experiment Video
Updated: Jul 6, 2025

Sleeve Gastrectomy in Mice using Surgical Clips
Published on: November 14, 2020
Metabolic and Bariatric Surgery in Children: Current Practices and Outcomes
Shayan A Shah1, Noor A Khan2, Faisal G Qureshi3
1Aga Khan University, Karachi, Pakistan.
Insights
Metabolic and Bariatric Surgery (MBS) offers safe and effective weight loss for children with obesity, improving related health issues. Laparoscopic sleeve gastrectomy is preferred, though few adolescents receive this treatment.
Area of Science:
- Pediatric Endocrinology
- Surgical Obesity Management
- Adolescent Health
Background:
- Childhood obesity is a growing epidemic with significant long-term health consequences.
- Metabolic and Bariatric Surgery (MBS) is increasingly considered for severe pediatric obesity.
- Current evidence on MBS in children requires synthesis to guide clinical practice.
Purpose of the Study:
- To review current evidence on Metabolic and Bariatric Surgery (MBS) in pediatric patients.
- To evaluate weight loss outcomes and improvement in comorbid conditions post-MBS.
- To compare surgical versus non-surgical interventions and propose an evidence-based approach.
Main Methods:
- Systematic review of current literature on pediatric MBS.
- Analysis of weight loss data and comorbid condition resolution.
- Comparison of MBS with pharmacologic and lifestyle interventions.
Main Results:
- Metabolic and Bariatric Surgery (MBS) is a safe and effective option for carefully selected pediatric patients, yielding significant and lasting weight loss.
- Laparoscopic sleeve gastrectomy (LSG) is the leading procedure due to its favorable safety profile.
- Despite proven benefits, MBS is underutilized in adolescents; new pharmacologic agents show promise but lack long-term data.
Conclusions:
- Metabolic and Bariatric Surgery (MBS) is a recommended and effective tool for managing pediatric obesity.
- Early referral to multidisciplinary teams is crucial for identifying suitable candidates.
- Further research is needed on long-term outcomes of both MBS and new pharmacologic therapies in children.
Purpose Of Review:
This review will examine the most current evidence for Metabolic and Bariatric Surgery (MBS) in the pediatric population, specifically in terms of weight loss outcomes and improvement in comorbid conditions and complications. Additionally, we compare surgical and non-surgical interventions, review current guidelines, and propose a stepwise evidence-based approach to the management of obesity in children.
Recent Findings:
MBS is a safe option for appropriately selected pediatric patients which leads to significant and sustained weight loss. This weight loss is associated with improvement of related comorbid conditions. Laparoscopic sleeve gastrectomy (LSG) has emerged as the procedure of choice with a better safety profile. Despite the evidence, very few adolescents undergo MBS. New pharmacologic agents specifically the GLP-1/GIP agents have shown early promise especially in patients under body mass index 40, but the long-term effects are unknown. MBS is an effective tool in the management of pediatric obesity, and its use has been recommended by professional societies. Early referral to a multidisciplinary obesity team can help identify appropriate patients.
Related Concept Videos
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...

